TABLE 6.
HTAD (see Table 7): syndromic |
■ Marfan syndrome |
■ Loeys-Dietz syndrome |
■ Vascular Ehlers-Danlos syndrome |
■ Smooth muscle dysfunction syndrome |
■ Others: attributable to pathogenic variants in FLNA, BGN, LOX |
|
HTAD (see Table 7): nonsyndromic |
■ ACTA2, MYH11, PRKG1, MYLK, and others |
■ Familial thoracic aortic aneurysm without identified pathogenic variants in a known gene for HTAD |
|
Congenital conditions |
■ Bicuspid aortic valve |
■ Turner syndrome |
■ Coarctation of the aorta |
■ Complex congenital heart defects (tetralogy of Fallot, transposition of the great vessels, truncus arteriosus) |
|
Hypertension |
|
Atherosclerosis |
|
Degenerative |
|
Previous aortic dissection |
|
Inflammatory aortitis |
■ Giant cell arteritis |
■ Takayasu arteritis |
■ Behçet disease |
■ Immunoglobulin G4-related disease, antineutrophil cytoplasmic antibody-related, sarcoidosis |
|
Infectious aortitis |
■ Bacterial, fungal, syphilitic |
|
Previous traumatic aortic injury |
HTAD indicates heritable thoracic aortic diseases; and TAA, thoracic aortic aneurysms.